share_log

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP: CORRESP

iBio Inc | CORRESP:信函
美股sec公告 ·  04/23 01:12
牛牛AI助理已提取核心訊息
iBio Inc, a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on April 16, 2024. The company seeks to have the registration become effective on April 24, 2024, at 4:00 p.m. Eastern Time. This request was communicated in a letter addressed to Jimmy McNamara at the SEC's Division of Corporation Finance. iBio Inc acknowledges its responsibilities under federal securities laws regarding the issuance of securities covered by the Registration Statement. Leslie Marlow of Blank Rome LLP has been authorized by iBio Inc to modify or withdraw the acceleration request if necessary. The SEC has been asked to notify Ms. Marlow once the acceleration has been granted.
iBio Inc, a biotechnology company, has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on April 16, 2024. The company seeks to have the registration become effective on April 24, 2024, at 4:00 p.m. Eastern Time. This request was communicated in a letter addressed to Jimmy McNamara at the SEC's Division of Corporation Finance. iBio Inc acknowledges its responsibilities under federal securities laws regarding the issuance of securities covered by the Registration Statement. Leslie Marlow of Blank Rome LLP has been authorized by iBio Inc to modify or withdraw the acceleration request if necessary. The SEC has been asked to notify Ms. Marlow once the acceleration has been granted.
生物技術公司iBio Inc已正式要求美國證券交易委員會(SEC)加快其S-3表格註冊聲明的生效日期,該聲明最初於2024年4月16日提交。該公司尋求使註冊於美國東部時間2024年4月24日下午4點生效。該請求是在寫給美國證券交易委員會公司財務部吉米·麥克納馬拉的一封信中提出的。iBio Inc承認根據聯邦證券法,其對註冊聲明所涵蓋證券的發行負有責任。Blank Rome LLP的萊斯利·馬洛已獲得iBio Inc的授權,可在必要時修改或撤回加速請求。加速批准後,美國證券交易委員會被要求通知馬洛女士。
生物技術公司iBio Inc已正式要求美國證券交易委員會(SEC)加快其S-3表格註冊聲明的生效日期,該聲明最初於2024年4月16日提交。該公司尋求使註冊於美國東部時間2024年4月24日下午4點生效。該請求是在寫給美國證券交易委員會公司財務部吉米·麥克納馬拉的一封信中提出的。iBio Inc承認根據聯邦證券法,其對註冊聲明所涵蓋證券的發行負有責任。Blank Rome LLP的萊斯利·馬洛已獲得iBio Inc的授權,可在必要時修改或撤回加速請求。加速批准後,美國證券交易委員會被要求通知馬洛女士。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。